Exploration of Musculoskeletal Diseases

Open Access Review

Multifaceted aspects of chronic disease: do diffuse idiopathic skeletal hyperostosis affect the quality of life?

Greta Pellegrino ... Piercarlo Sarzi-Puttini

Published: January 23, 2024 Explor Musculoskeletal Dis. 2024;2:31–39

DOI: https://doi.org/10.37349/emd.2024.00031

This article belongs to the special issue Diffuse Idiopathic Skeletal Hyperostosis- A common but neglected disease

Full Text PDF

2389 30 1

Open Access Mini Review

Can Janus kinase inhibitors be used to treat immune checkpoint inhibitor associated adverse events?

Jürgen Braun, Kirsten Karberg

Published: November 04, 2024 Explor Musculoskeletal Dis. 2024;2:490–497

DOI: https://doi.org/10.37349/emd.2024.00073

Full Text PDF

1010 30 0

Open Access Perspective

Selecting the best-value biosimilar in emerging countries

Gilberto Castañeda-Hernández

Published: September 14, 2024 Explor Musculoskeletal Dis. 2024;2:423–430

DOI: https://doi.org/10.37349/emd.2024.00067

This article belongs to the special issue Biosimilars: State of the Art in the Treatment of Rheumatic Diseases

Full Text PDF

1460 29 0

Open Access Perspective

Universal screening for developmental dysplasia of the hip in Austria: what have we learned?

Tanja Kraus, Catharina Chiari

Published: June 03, 2024 Explor Musculoskeletal Dis. 2024;2:208–215

DOI: https://doi.org/10.37349/emd.2024.00049

This article belongs to the special issue Baby Hip Sonography Worldwide: Experience, Results, and Recommendations

Full Text PDF

1661 28 0

Open Access Original Article

Nonlinear modification to Hildebrand equation for accelerometry assessment of physical activity: improved accuracy for low activity levels

Laura A. Frey-Law ... Kathleen A. Sluka

Published: September 13, 2024 Explor Musculoskeletal Dis. 2024;2:408–422

DOI: https://doi.org/10.37349/emd.2024.00066

Full Text PDF

1103 27 0

Open Access Perspective

Opportunities of digital health technologies for rheumatology: from clinics to quality and research

Michael Schirmer ... Johannes D. Pallua

Published: April 08, 2024 Explor Musculoskeletal Dis. 2024;2:82–91

DOI: https://doi.org/10.37349/emd.2024.00037

This article belongs to the special issue Digital health technologies in rheumatology: emerging evidence and innovation

Full Text PDF

2374 27 1

Open Access Original Article

Prevalence and factors associated to diffuse idiopathic skeletal hyperostosis in gout

Fernando Pérez-Ruiz ... Ana María Herrero-Beites

Published: September 27, 2023 Explor Musculoskeletal Dis. 2023;1:121–127

DOI: https://doi.org/10.37349/emd.2023.00016

This article belongs to the special issue Diffuse Idiopathic Skeletal Hyperostosis- A common but neglected disease

Full Text PDF

1527 26 1

Open Access Perspective

Nutritional problems in rheumatoid arthritis patients with temporomandibular joint involvement

Manolya Ilhanli, Ilker Ilhanli

Published: October 31, 2023 Explor Musculoskeletal Dis. 2023;1:180–185

DOI: https://doi.org/10.37349/emd.2023.00020

This article belongs to the special issue Comorbidities in rheumatoid arthritis

Full Text PDF

2009 26 0

Open Access Original Article

Morphological variations at the knee associated with osteoarthritis: a case-control study using data from the GOAL study

Anand Ramachandran Nair ... Abhishek Abhishek

Published: June 30, 2023 Explor Musculoskeletal Dis. 2023;1:68–76

DOI: https://doi.org/10.37349/emd.2023.00011

Full Text PDF

1480 26 1

Open Access Original Article

Validation of computer-based analysis of static ultrasound images of patellar and Achilles tendon enthesis territories

Carlos A. Guillén-Astete ... Mónica Vázquez-Díaz

Published: May 15, 2024 Explor Musculoskeletal Dis. 2024;2:148–155

DOI: https://doi.org/10.37349/emd.2024.00044

This article belongs to the special issue Digital health technologies in rheumatology: emerging evidence and innovation

Full Text PDF

1273 26 0

Open Access Short Communication

Transition from reference adalimumab to biosimilar SB5 in patients with rheumatoid arthritis: sub-analysis of Spanish patients in the PROPER study

Fernando Pérez-Ruiz ... Eugenio Chamizo Carmona

Published: February 10, 2025 Explor Musculoskeletal Dis. 2025;3:100784

DOI: https://doi.org/10.37349/emd.2025.100784

This article belongs to the special issue Biosimilars: State of the Art in the Treatment of Rheumatic Diseases

Full Text PDF

1228 26 0

Open Access Original Article

Association of mutations in hemochromatosis genes with clinical severity of calcium pyrophosphate arthritis

Joana Atxotegi-Saenz de Buruaga ... Fernando Perez-Ruiz

Published: October 31, 2023 Explor Musculoskeletal Dis. 2023;1:186–193

DOI: https://doi.org/10.37349/emd.2023.00021

Full Text PDF

2379 25 1

Open Access Review

The reality of sonography of the infant hip in Brazil: results and recommendations

Giovanna Galvão Braga Motta ... Alexandre Francisco de Lourenço

Published: May 20, 2024 Explor Musculoskeletal Dis. 2024;2:156–163

DOI: https://doi.org/10.37349/emd.2024.00045

This article belongs to the special issue Baby Hip Sonography Worldwide: Experience, Results, and Recommendations

Full Text PDF

1431 25 1

Open Access Editorial

Calcium pyrophosphate crystal deposition disease—what’s new?

Jürgen Braun

Published: December 06, 2023 Explor Musculoskeletal Dis. 2023;1:257–263

DOI: https://doi.org/10.37349/emd.2023.00027

This article belongs to the special issue Calcium Pyrophosphate Deposition Disease

Full Text PDF

1700 24 1

Open Access Review

Chronic pain, fibromyalgia, and long COVID

Jürgen Braun

Published: January 22, 2025 Explor Musculoskeletal Dis. 2025;3:100780

DOI: https://doi.org/10.37349/emd.2025.100780

Full Text PDF

2168 24 0

Open Access Original Article

Successful implementation of interchange of biologic medications in chronic arthritis after information of costs to prescribers

Fernando Perez-Ruiz ... Amaya de Basagoiti-Gorordo

Published: September 10, 2024 Explor Musculoskeletal Dis. 2024;2:384–390

DOI: https://doi.org/10.37349/emd.2024.00064

This article belongs to the special issue Biosimilars: State of the Art in the Treatment of Rheumatic Diseases

Full Text PDF

1248 23 1

Open Access Editorial

Sarcopenia, a hidden comorbidity of established rheumatoid arthritis

Joan M. Nolla

Published: July 19, 2024 Explor Musculoskeletal Dis. 2024;2:293–299

DOI: https://doi.org/10.37349/emd.2024.00057

This article belongs to the special issue Comorbidities in rheumatoid arthritis

Full Text PDF

1374 22 0

Open Access Case Report

How to treat a patient with psoriatic arthritis and chronic lymphocytic leukemia?

Jürgen Braun ... Denis Poddubnyy

Published: June 20, 2024 Explor Musculoskeletal Dis. 2024;2:235–241

DOI: https://doi.org/10.37349/emd.2024.00051

Full Text PDF

1927 22 1

Open Access Original Article

The ‘FebBenz’ approach for severe difficult-to-treat gout

Enrique Calvo-Aranda ... Marta Novella-Navarro

Published: May 22, 2025 Explor Musculoskeletal Dis. 2025;3:100793

DOI: https://doi.org/10.37349/emd.2025.100793

This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout

Full Text PDF

514 22 0

Open Access Commentary

Addressing weight loss management in obese gout patients: guidance for future trials

Robin Christensen ... Lisa K. Stamp

Published: November 07, 2024 Explor Musculoskeletal Dis. 2024;2:498–508

DOI: https://doi.org/10.37349/emd.2024.00074

This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout

Full Text PDF

2582 22 0